Elmind Capital »

Pharvaris N V shares owned by Elmind Capital

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 476k 28.25

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Commodore Capital
Wellington Management Company
Novo A/S
Saturn V Capital Management
Point72 Asset Management
Cormorant Asset Management
Sofinnova Ventures

View all funds holding Pharvaris N V